Companies that are testing medical technology often get up into the several dollar range. BEFORE they even start testing... they don't sit at 0.30. Undervalued stocks are good investments.
Health Canada will approve what works. They know Na-NOSE works, they are getting the patient data to show Health Canada now. Not only that, it's been posted on their website several times that Health Minister's in Canada have been on board and have granted their approval to do these trials.
They have the government on board and watching patiently.
I disagree with your rationale. The key is FDA approval not Health Canada. Keep in mind Breathtec is not a Canadian company. It is an American company. Innovation Boulevard was targeted for clinical trial purposes because of the diversity of population it offers . As far as the Crystal Ball Theory that a marketable product for the Na-Nose device is years in the making is premature and misinformed IMO. There is a litany of prior research built into Na-Nose prior to Breathtec acquiring a licensing agreement. Millions invested in 5 countries across the globe. Not to mentioned the 21st Century Cures Act was recently signed into law that basically fast tracks the road to FDA approval. Thier approval will secure global acceptance (reciprocity). Does anyone know what country is the HUB of all things cannabis around the world? It's Israel. Check a couple stocks from Anthony Cataldo's last article regarding the 227 or so companies in the marijuana space. Many have business ties back to Israeli institutions. Enter Dr. Hossam Haick & Na-Nose. This stuff has been cooking for decades and now boiling to the surface, One Israel connected stock I have been watching only - since Cataldo's article is OWCP. An Israel connected company. There are other Israel connected companies making serious moves on the OTC specifically in the MedTech space. Breathtec Is poised to be yet another. To my sister company shareholders...emotions aside...play the hand you're dealt! Let's get this money.
News 
Market Data 
Discover 
